OP Asset Management »

Sarepta Therapeutics shares owned by OP Asset Management

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by OP Asset Management from 13F filings

Historical chart of OP Asset Management investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by OP Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by OP Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.2M 67k 17.97
2026-03-31 $218k 10k 21.76

More positions owned by OP Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Micron Technology (MU)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Advanced Micro Devices (AMD)
JPMorgan Chase & Co. (JPM)

View all positions for OP Asset Management

Top funds holding Sarepta Therapeutics

BlackRock
Vanguard Portfolio Management
State Street Corporation
AQR Capital Management
Two Sigma Investments
Vanguard Capital Management
First Trust Advisors
RA Capital Management
Susquehanna International
Morgan Stanley
Erste Asset Management GmbH
Citadel Advisors
UBS Group
Standard Life Aberdeen
Bank of America Corporation

View all funds holding Sarepta Therapeutics